FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masafumi Fukagawa

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Procedures

Renal Dialysis

Living Beings

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Tomoya Umezono; Moritsugu Kimura; Masumi Kondo; Yusuke Kuriyama; Han Miyatake; Masaaki Miyauchi; Hiroki Sato; Daisuke Suzuki; Eitaro Tanaka; Masao Toyoda; Masafumi Fukagawa
Long-term glycemic control in Japanese type 2 diabetes patients after switching treatment from twice-daily premixed insulin to once daily insulin glargine.
Genta Kanai; Masafumi Fukagawa
[Bone mineral metabolism that kidney controls].
Daisuke Suzuki; Eitaro Tanaka; Masao Toyoda; Tomoya Umezono; Naoyuki Yamamoto; Moritugu Kimura; Yusuke Kuriyama; Han Miyatake; Masaaki Miyauchi; Hiroki Sato; Makiko Abe; Masafumi Fukagawa
Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masafumi Fukagawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tomoya Umezono; Moritsugu Kimura; Masumi Kondo; Yusuke Kuriyama; Han Miyatake; Masaaki Miyauchi; Hiroki Sato; Daisuke Suzuki; Eitaro Tanaka; Masao Toyoda; Masafumi Fukagawa
Long-term glycemic control in Japanese type 2 diabetes patients after switching treatment from twice-daily premixed insulin to once daily insulin glargine.
The Tokai journal of experimental and clinical medicine 2013;38(1):28-32.
2013: Genta Kanai; Masafumi Fukagawa
[Bone mineral metabolism that kidney controls].
Clinical calcium 2013;23(2):165-71.
2013: Daisuke Suzuki; Eitaro Tanaka; Masao Toyoda; Tomoya Umezono; Naoyuki Yamamoto; Moritugu Kimura; Yusuke Kuriyama; Han Miyatake; Masaaki Miyauchi; Hiroki Sato; Makiko Abe; Masafumi Fukagawa
Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus.
Internal medicine (Tokyo, Japan) 2013;52(10):1029-34.
2013: Masahiro Koizumi; Hirotaka Komaba; Masafumi Fukagawa
Parathyroid Function in Chronic Kidney Disease: Role of FGF23-Klotho Axis.
Contributions to nephrology 2013;180():110-23.
2013: Keiji Kono; Kentaro Nakai; Masami Shinohara; Hideki Fujii; Masafumi Fukagawa; Shunsuke Goto; Michinori Hirata; Riko Kitazawa; Sohei Kitazawa; Shinichi Nishi
Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats.
American journal of nephrology 2013;37(2):167-74.
2013: Moritsugu Kimura; Masamichi Komatsu; Makoto Nishina; Jaeduk Yoshimura Noh; Hideki Ozawa; Toshiro Seki; Sakurako Tajiri; Masafumi Fukagawa; Toru Ishihara; Hidetaka Yanagi; Atsushi Takagi
The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Endocrine journal 2013;60(3):383-8.
2012: Hirotaka Komaba; Masafumi Fukagawa
Vitamin D and secreted Klotho: a long-awaited panacea for vascular calcification?
Kidney international 2012;82(12):1248-50.
2012: Masafumi Fukagawa; Tadao Akizawa; Shingo Fukuma; Takeshi Hasegawa; Kiyoshi Kurokawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Shunichi Fukuhara
Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(9):1473-80.
2012: Hirotaka Komaba; Masafumi Fukagawa
The role of FGF23 in CKD--with or without Klotho.
Nature reviews. Nephrology 2012;8(8):484-90.
2012: Keiji Kono; Kentaro Nakai; Junya Shite; Hideki Fujii; Masafumi Fukagawa; Shunsuke Goto; Ken-Ichi Hirata; Shinichi Nishi
Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease.
Kidney international 2012;82(3):344-51.
2012: Hirotaka Komaba; Kensuke Moriwaki; Masatomo Taniguchi; Shunsuke Yamada; Shunsuke Goto; Takatoshi Kakuta; Isao Kamae; Masafumi Fukagawa
Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(2):262-71.
2011: Y Takeda; Michio Umezu; Y Yamaguchi; A Abe; H Hayakawa; K Hirano; T Hosoya; K Ichida; S Nakanishi; I Ohno; Masafumi Fukagawa
Two cases of nephrotic syndrome (NS)-induced acute kidney injury (AKI) associated with renal hypouricemia.
Clinical nephrology 2011;76(1):78-82.
2011: Yoshiko Iwasaki; Junichiro James Kazama; Hideyuki Yamato; Masafumi Fukagawa
Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.
Bone 2011;48(6):1260-7.
2011: Yoshiko Iwasaki; Hideyuki Yamato; Masafumi Fukagawa
Treatment with pravastatin attenuates oxidative stress and protects osteoblast cell viability from indoxyl sulfate.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15(2):151-5.
2011: Shunsuke Goto; Kunihiko Yoshiya; Tomoyuki Kita; Hideki Fujii; Masafumi Fukagawa
Uremic toxins and oral adsorbents.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15(2):132-4.
2011: Hideki Fujii; Kentaro Nakai; Masafumi Fukagawa
Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15(2):125-8.
2011: Shunsuke Goto; Yasuhiro Hamada; Riko Kitazawa; Sohei Kitazawa; Keiji Kono; Kentaro Nakai; Shinichi Nishi; Masami Shinohara; Hideyuki Yamato; Hideki Fujii; Masafumi Fukagawa
Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.
American journal of nephrology 2011;34(3):281-90.
2011: Hideki Fujii; Jong-Il Kim; Shinichi Nishi; Kunihiko Yoshiya; Masafumi Fukagawa
Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study.
American journal of nephrology 2011;34(2):126-34.
2011: Yoko Takeda; Hirotaka Komaba; Shunsuke Goto; Hideki Fujii; Michio Umezu; Hirohito Hasegawa; Akira Fujimori; Masato Nishioka; Shinichi Nishi; Masafumi Fukagawa
Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients.
American journal of nephrology 2011;33(5):421-6.
2011: Kentaro Nakai; Hideki Fujii; Keiji Kono; Shunsuke Goto; Masafumi Fukagawa; Shinichi Nishi
Effects of AST-120 on left ventricular mass in predialysis patients.
American journal of nephrology 2011;33(3):218-23.
2010: Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Keiji Kono; Shunsuke Goto; Hirotaka Komaba; Hideki Fujii; Yasuhiko Yamamoto; Hiroshi Yamamoto; Makoto Usami; Masafumi Fukagawa
The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.
Endocrine 2010;38(3):369-76.
2010: Kentaro Nakai; Hirotaka Komaba; Masafumi Fukagawa
New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
Journal of nephrology 2010;23(6):619-25.
2010: Shunsuke Goto; Hideki Fujii; Yasuhiro Hamada; Kunihiko Yoshiya; Masafumi Fukagawa
Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2010;14(4):417-23.
2010: Kazuhiro Shiizaki; Ikuji Hatamura; Masafumi Fukagawa; Eiko Nakazawa; Fumie Saji; Yuko Watanabe; Tadao Akizawa; Eiji Kusano
Development of a technique for introduction of an expressed complementary deoxyribonucleic acid into parathyroid cells by direct injection.
Endocrinology 2010;151(8):4031-8.
2010: Hirotaka Komaba; Masafumi Fukagawa
FGF23-parathyroid interaction: implications in chronic kidney disease.
Kidney international 2010;77(4):292-8.
2010: Hirotaka Komaba; Jeongsoo Shin; Masafumi Fukagawa
Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(2):638-41.
2010: Hirotaka Komaba; Shunsuke Goto; Hideki Fujii; Yasuhiro Hamada; Akira Kobayashi; Koji Shibuya; Yoshihiro Tominaga; Naoki Otsuki; Ken-Ichi Nibu; Kimie Nakagawa; Naoko Tsugawa; Toshio Okano; Riko Kitazawa; Masafumi Fukagawa; Tomoyuki Kita
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
Kidney international 2010;77(3):232-8.
2010: Hideki Fujii; Keiji Kono; Kentaro Nakai; Shunsuke Goto; Hirotaka Komaba; Yasuhiro Hamada; Masami Shinohara; Riko Kitazawa; Sohei Kitazawa; Masafumi Fukagawa
Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.
American journal of nephrology 2010;31(4):342-52.
2010: Masahide Fukuda; Yoriko Nakanishi; Masanori Fuse; Norihide Yokoi; Yasuhiro Hamada; Masafumi Fukagawa; Akira Negi; Makoto Nakamura
Altered expression of aquaporins 1 and 4 coincides with neurodegenerative events in retinas of spontaneously diabetic Torii rats.
Experimental eye research 2010;90(1):17-25.
2009: Hirotaka Komaba; Kensuke Moriwaki; Isao Kamae; Masafumi Fukagawa
Towards cost-effective strategies for treatment of chronic kidney disease-mineral and bone disorder in Japan.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2009;13 Suppl 1():S28-35.
2009: Kentaro Nakai; Hirotaka Komaba; Masafumi Fukagawa
Management of mineral and bone disorder in chronic kidney disease: quo vadis?
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2009;13 Suppl 1():S2-6.
2009: Yasuhiro Hamada; Hideki Fujii; Masafumi Fukagawa
Role of oxidative stress in diabetic bone disorder.
Bone 2009;45 Suppl 1():S35-8.
2009: Hideki Fujii; Fuyuhiko Nishijima; Sumie Goto; Mikio Sugano; Hideyuki Yamato; Riko Kitazawa; Sohei Kitazawa; Masafumi Fukagawa
Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(7):2089-95.
2009: Shunsuke Goto; Masafumi Fukagawa
[Clinical aspect of recent progress in phosphate metabolism. Pathophysiology of secondary hyperparathyroidism in chronic kidney disease].
Clinical calcium 2009;19(6):809-14.
2009: Hirotaka Komaba; Masafumi Fukagawa
Fetuin-mineral complex: a new potential biomarker for vascular calcification?
Kidney international 2009;75(9):874-6.
2009: Yasuhiro Hamada; Masafumi Fukagawa
Is hepcidin the star player in iron metabolism in chronic kidney disease?
Kidney international 2009;75(9):873-4.
2009: Yasuhiro Hamada; Hideki Fujii; Riko Kitazawa; Junji Yodoi; Sohei Kitazawa; Masafumi Fukagawa
Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications.
Bone 2009;44(5):936-41.
2009: Yasuhiro Hamada; Masafumi Fukagawa
[Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
Clinical calcium 2009;19(4):486-92.
2009: Hirotaka Komaba; Shunsuke Goto; Masafumi Fukagawa
Critical issues of PTH assays in CKD.
Bone 2009;44(4):666-70.
2009: Hirotaka Komaba; Masafumi Fukagawa
Regression of parathyroid hyperplasia by calcimimetics--fact or illusion?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(3):707-9.
2009: Hirotaka Komaba; Masafumi Fukagawa
[Disturbance of phosphorus metabolism in chronic kidney disease].
Clinical calcium 2009;19(2):166-72.
2009: Jun Ito; Masafumi Fukagawa
Predicting the risk of acute kidney injury in earthquake victims.
Nature clinical practice. Nephrology 2009;5(2):64-5.
2009: Yoko Takeda; Aya Abe; Takeshi Toki; Hirotaka Komaba; Takaya Abe; Michio Umezu; Kensuke Joh; Masafumi Fukagawa
[Case of goodpasture syndrome associated with minimal change nephrotic syndrome (MCNS) in a patient with rheumatoid arthritis (RA)].
Nihon Jinzo Gakkai shi 2009;51(7):897-903.
2009: Hideki Fujii; Keiji Kono; Shunsuke Goto; Tetsuari Onishi; Hiroya Kawai; Ken-ichi Hirata; Kiyoko Hattori; Kimitoshi Nakamura; Fumio Endo; Masafumi Fukagawa
Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease.
American journal of nephrology 2009;30(6):527-35.
2009: H Komaba; Masafumi Fukagawa
FGF23: a key player in mineral and bone disorder in CKD.
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2009;29(5):392-6.
2008: Hirotaka Komaba; Masafumi Fukagawa
Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN1493 study.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12 Suppl 1():S44-9.
2008: Daisuke Tsuchihashi; Takaya Abe; Hirotaka Komaba; Hideki Fujii; Yasuhiro Hamada; Tomoko Nii-Kono; Motoko Tanaka; Masafumi Fukagawa
Serum pro-hepcidin as an indicator of iron status in dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12(3):226-31.
2008: Hideki Fujii; Shin Takiuchi; Yuhei Kawano; Masafumi Fukagawa
Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
American journal of hypertension 2008;21(6):650-6.
2008: Yasuhiro Hamada; Tomoko-Nii Kono; Yoshiyuki Moriguchi; Masato Higuchi; Masafumi Fukagawa
Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):1886-91.
2008: Yasuhiro Hamada; Masafumi Fukagawa
[Relationship between lipid and glucose metabolism and bone mineral metabolism : pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia].
Clinical calcium 2008;18(5):671-6.
2008: Hirotaka Komaba; Yoko Takeda; Takaya Abe; Keitaro Komaba; Naoki Otsuki; Ken-ichi Nibu; Michio Umezu; Masafumi Fukagawa
Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(5):1760-2.
2008: Hideki Fujii; Yasuhiro Hamada; Masafumi Fukagawa
Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats.
Bone 2008;42(2):372-9.
2008: Hideki Fujii; Akira Fukuda; Motoko Tanaka; Yoko Kojima; Tatsuro Ishida; Ken-Ichi Hirata; Masafumi Fukagawa
Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.
American journal of nephrology 2008;28(6):974-81.
2008: Hirotaka Komaba; Motoko Tanaka; Masafumi Fukagawa
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Internal medicine (Tokyo, Japan) 2008;47(11):989-94.
2008: Hirotaka Komaba; Masafumi Fukagawa
[Basic and clinical aspects of calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation].
Clinical calcium 2008;18(1):60-6.
2008: Kazuhiro Shiizaki; Masafumi Fukagawa; Qunsheng Yuan; Ikuji Hatamura; Tomoko Nii-Kono; Fumie Saji; Takashi Shigematsu; Tadao Akizawa
Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
American journal of nephrology 2008;28(1):59-66.
2008: Masafumi Fukagawa; Shigeru Yumita; Tadao Akizawa; Eiji Uchida; Yusuke Tsukamoto; Manabu Iwasaki; Shozo Koshikawa
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(1):328-35.
2007: Shunsuke Goto; Masafumi Fukagawa
[Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
Clinical calcium 2007;17(12):1830-4.
2007: Masafumi Fukagawa; Junichiro James Kazama
The making of a bone in blood vessels: from the soft shell to the hard bone.
Kidney international 2007;72(5):533-4.
2007: Hirotaka Komaba; Masafumi Fukagawa
Should clinicians follow the K/DOQI guidelines for treating hyperphosphatemia with sevelamer?
Nature clinical practice. Nephrology 2007;3(8):418-9.
2007: Masafumi Fukagawa
Nephrology in earthquakes: sharing experiences and information.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(4):803-8.
2007: Yasuhiro Hamada; Satoshi Miyata; Tomoko Nii-Kono; Riko Kitazawa; Sohei Kitazawa; Satomi Higo; Michiru Fukunaga; Shigemitsu Ueyama; Hajime Nakamura; Junji Yodoi; Masafumi Fukagawa; Masato Kasuga
Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1547-57.
2007: Yasuhiro Hamada; Masafumi Fukagawa
[The pleiotropic effects of vitamin D on kidney disease].
Clinical calcium 2007;17(5):712-7.
2007: Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Hideki Fujii; Masato Kasuga; Masafumi Fukagawa
Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
Bone 2007;40(5):1408-14.
2007: Tomoko Nii-Kono; Yoshiko Iwasaki; Motoyuki Uchida; Ayako Fujieda; Atsuko Hosokawa; Masaru Motojima; Hideyuki Yamato; K Kurokawa; Masafumi Fukagawa
Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.
Kidney international 2007;71(8):738-43.
2007: Hideki Fujii; Jong Il Kim; Takaya Abe; Michio Umezu; Masafumi Fukagawa
Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients.
Internal medicine (Tokyo, Japan) 2007;46(18):1507-12.
2007: Hideki Fujii; Takaya Abe; Michio Umezu; Masafumi Fukagawa
Tako-tsubo cardiomyopathy associated with brain metastasis of seminoma in a patient with chronic kidney disease.
Internal medicine (Tokyo, Japan) 2007;46(17):1419-23.
2007: Yasuhiro Hamada; Masafumi Fukagawa
A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
The Kobe journal of medical sciences 2007;53(1-2):53-61.
2007: H Komaba; Y Takeda; Masafumi Fukagawa
Extensive deep vein thrombosis in a postpartum woman with Behçet's disease associated with nephrotic syndrome.
Kidney international 2007;71(1):6.
2006: Masafumi Fukagawa; Junichiro James Kazama
FGF23: its role in renal bone disease.
Pediatric nephrology (Berlin, Germany) 2006;21(12):1802-6.
2006: Yoshiko Iwasaki; Hideyuki Yamato; Tomoko Nii-Kono; Ayako Fujieda; Motoyuki Uchida; Atsuko Hosokawa; Masaru Motojima; Masafumi Fukagawa
Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(10):2768-74.
2006: Masafumi Fukagawa; Shohei Nakanishi; Hideki Fujii; Yasuhiro Hamada; Takaya Abe
Regulation of parathyroid function in chronic kidney disease (CKD).
Clinical and experimental nephrology 2006;10(3):175-9.
2006: Yasuhiro Hamada; Masafumi Fukagawa
[Chronic kidney disease-mineral and bone disorder (CKD-MBD)].
Nihon rinsho. Japanese journal of clinical medicine 2006;64(9):1703-6.
2006: Yoshiko Iwasaki; Hideyuki Yamato; Tomoko Nii-Kono; Ayako Fujieda; Motoyuki Uchida; Atsuko Hosokawa; Masaru Motojima; Masafumi Fukagawa
Insufficiency of PTH action on bone in uremia.
Kidney international. Supplement 2006;(102):S34-6.
2006: Masafumi Fukagawa; Shohei Nakanishi; Junichiro James Kazama
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
Kidney international. Supplement 2006;(102):S3-7.
2006: Toshio Arakawa; Pierre D'Amour; Louise Rousseau; Jean-Hugues Brossard; Makoto Sakai; Hiroomi Kasumoto; Naoya Igaki; Takeo Goto; Tom Cantor; Masafumi Fukagawa
Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(3):525-31.
2006: Masafumi Fukagawa
Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
Nature clinical practice. Nephrology 2006;2(5):248-9.
2006: Yoshiko Iwasaki; Masafumi Fukagawa
[Molecular biology in regulation of kidney functions: Vitamin D3].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 2():234-7.
2006: Hiroshi Nishi; Tomoko Nii-Kono; K Ikeda; A Fujimori; Masafumi Fukagawa
No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism.
Clinical nephrology 2006;65(2):149-50.
2006: Ashok Pradhan; Michio Umezu; Masafumi Fukagawa
Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension.
American journal of nephrology 2006;26(6):552-61.
2006: Masafumi Fukagawa; Yasuhiro Hamada; Shohei Nakanishi; Motoko Tanaka
The kidney and bone metabolism: Nephrologists' point of view.
Journal of bone and mineral metabolism 2006;24(6):434-8.
2006: Yoshiko Iwasaki; Hideyuki Yamato; Tomoko Nii-Kono; Ayako Fujieda; Motoyuki Uchida; Atsuko Hosokawa; Masaru Motojima; Masafumi Fukagawa
Uremic toxin and bone metabolism.
Journal of bone and mineral metabolism 2006;24(2):172-5.
2006: Masafumi Fukagawa; Tadao Akizawa
Calcium abnormalities of dialysis patients.
Journal of bone and mineral metabolism 2006;24(2):160.
2006: Hiroshi Nishi; A Abe; A Kita; T Toki; N Noda; D Tsuchihashi; T Abe; M Umezu; H Yokozaki; Masafumi Fukagawa
Cerebral venous thrombosis in adult nephrotic syndrome due to systemic amyloidosis.
Clinical nephrology 2006;65(1):61-4.
2005: Masafumi Fukagawa
Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?
Nature clinical practice. Nephrology 2005;1(1):20-1.
2005: Shohei Nakanishi; Masafumi Fukagawa
[Secondary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():341-6.
2005: Yoshiko Iwasaki-Ishizuka; Hideyuki Yamato; Tomoko Nii-Kono; Kiyoshi Kurokawa; Masafumi Fukagawa
Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(9):1904-11.
2005: Fumihiko Koiwa; Junichiro James Kazama; Akihide Tokumoto; Noritaka Onoda; Hitoshi Kato; Tomoyuki Okada; Tomoko Nii-Kono; Masafumi Fukagawa; Takashi Shigematsu
Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(4):336-9.
2005: Shohei Nakanishi; Masafumi Fukagawa
[Functional disorder of the parathyroid gland and vascular calcification in hemodialysis patients].
Clinical calcium 2005;15(7):119-23.
2005: Masafumi Fukagawa; Tomoko Nii-Kono; Junichiro James Kazama
Role of fibroblast growth factor 23 in health and in chronic kidney disease.
Current opinion in nephrology and hypertension 2005;14(4):325-9.
2005: Shohei Nakanishi; Junichiro James Kazama; Tomoko Nii-Kono; Kentaro Omori; Takeyoshi Yamashita; Seiji Fukumoto; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.
Kidney international 2005;67(3):1171-8.
2005: Yoshiko Iwasaki-Ishizuka; Hideyuki Yamato; Hisashi Murayama; Ikuko Ezawa; Kiyoshi Kurokawa; Masafumi Fukagawa
Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy.
Life sciences 2005;76(15):1721-34.
2005: Hiroshi Nishi; Takashi Sato; Toru Kurihara; Takeshi Kurosawa; Masafumi Fukagawa
Control of parathyroid function in patients with a short history of hemodialysis.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(1):39-43.
2005: Hiroshi Nishi; Tomoko Nii-Kono; Shohei Nakanishi; Yuji Yamazaki; Takeyoshi Yamashita; Seiji Fukumoto; Kazuto Ikeda; Akira Fujimori; Masafumi Fukagawa
Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism.
Nephron. Clinical practice 2005;101(2):c94-9.
2004: Hiroshi Nishi; Shohei Nakanishi; Masafumi Fukagawa
[Whole-PTH assay--new method for assessment of parathyroid function].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():569-73.
2004: Takaya Abe; Mineo Shono; Toshihiro Kodama; Yuji Kita; Masafumi Fukagawa; Tadao Akizawa
Extracorporeal albumin dialysis.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(3):217-22.
2004: Takaya Abe; Hirotsugu Kobata; Yoshiyuki Hanba; Yukiko Kitabata; Nobuhiko Narukawa; Hirohito Hasegawa; Tomiya Abe; Masafumi Fukagawa
Study of plasma exchange for liver failure: beneficial and harmful effects.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(3):180-4.
2004: Hiroshi Nishi; Masafumi Fukagawa
[Clinical application of calcimimetics].
Clinical calcium 2004;14(5):756-9.
2003: Masafumi Fukagawa; Yoshiko Iwasaki; Junichiro James Kazama
Skeletal resistance to parathyroid hormone as a background abnormality in uremia.
Nephrology (Carlton, Vic.) 2003;8 Suppl():S50-2.
2003: Yoshiko Iwasaki-Ishizuka; Hideyuki Yamato; Hisashi Murayama; Masako Abe; Kei Takahashi; Kiyoshi Kurokawa; Masafumi Fukagawa; Ikuko Ezawa
Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats.
Journal of nutritional science and vitaminology 2003;49(4):256-61.
2003: Shohei Nakanishi; Takeshi Toki; Masafumi Fukagawa
[Calcium and vitamin D metabolism in the kidney-parathyroid system].
Clinical calcium 2003;13(7):856-62.
2003: Shohei Nakanishi; Shozo Yano; Rikako Nomura; Tatsuo Tsukamoto; Yasushi Shimizu; Jeongsoo Shin; Masafumi Fukagawa
Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii47-9.
2003: Masafumi Fukagawa; Shohei Nakanishi
Role of parathyroid intervention in the management of secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii23-6.
2003: Yoshiko Iwasaki; Hideyuki Yamato; Hisashi Murayama; Masami Sato; Takeshi Takahashi; Ikuko Ezawa; Kiyoshi Kurokawa; Masafumi Fukagawa
Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats.
Journal of bone and mineral metabolism 2003;21(3):154-60.
2002: Shohei Nakanishi; Masafumi Fukagawa
[Mechanism of secondary hyperparathyroidism].
Clinical calcium 2002;12(12):1625-30.
2002: Yoshiko Iwasaki; Hideyuki Yamato; Hisashi Murayama; Takeshi Takahashi; Ikuko Ezawa; Kiyoshi Kurokawa; Masafumi Fukagawa
Menatetrenone prevents osteoblast dysfunction in unilateral sciatic neurectomized rats.
Japanese journal of pharmacology 2002;90(1):88-93.
2002: Masafumi Fukagawa; Kiyoshi Kurokawa
[Renal osteodystrophy and secondary hyperparathyroidism].
Clinical calcium 2002;12(6):707-10.
2002: Norio Hanafusa; Yutaka Yatomi; Koei Yamada; Yuichi Hori; Masaomi Nangaku; Toshihiro Okuda; Toshiro Fujita; Kiyoshi Kurokawa; Masafumi Fukagawa
Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(4):580-6.
2002: Masafumi Fukagawa; Junichiro James Kazama; Kiyoshi Kurokawa
Renal osteodystrophy and secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():2-5.
2002: Yoshiko Iwasaki; Hideyuki Yamato; Hisashi Murayama; Masami Sato; Takeshi Takahashi; Ikuko Ezawa; Kiyoshi Kurokawa; Masafumi Fukagawa
Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension.
Journal of bone and mineral metabolism 2002;20(4):216-22.
2001: S Nakanishi; Junichiro James Kazama; Takashi Shigematsu; Yoshiko Iwasaki; Tom Cantor; T Kurosawa; Masafumi Fukagawa
Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S172-4.
2001: Masafumi Fukagawa; Junichiro James Kazama; Takashi Shigematsu
Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S152-5.
2001: Shohei Nakanishi; Masafumi Fukagawa
[PTH assay: new and future].
Clinical calcium 2001;11(8):1019-23.
2001: Masafumi Fukagawa; Junichiro James Kazama; Takashi Shigematsu
[PTH and bone metabolism in chronic dialysis patients].
Rinsho byori. The Japanese journal of clinical pathology 2001;49(3):236-8.
2000: Masafumi Fukagawa; Tadao Akizawa; Kiyoshi Kurokawa
Is aplastic osteodystrophy a disease of malnutrition?
Current opinion in nephrology and hypertension 2000;9(4):363-7.
1999: Masafumi Fukagawa
Cell biology of parathyroid hyperplasia in uremia.
The American journal of the medical sciences 1999;317(6):377-82.
1999: Masafumi Fukagawa; Y Iwasaki
Molecular pathogenesis of secondary hyperparathyroidism in renal failure: basic and clinical aspects.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 1():61-2.
1998: T Shimizu; T Kuroda; S Hata; Masafumi Fukagawa; S B Margolin; Kiyoshi Kurokawa
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.
Kidney international 1998;54(1):99-109.
1998: Yuichi Hori; T Katoh; M Hirakata; N Joki; Shinya Kaname; Masafumi Fukagawa; Toshihiro Okuda; H Ohashi; Tomoyuki Fujita; Kohei Miyazono; Kiyoshi Kurokawa
Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells.
Kidney international 1998;53(6):1616-25.
1997: Takao Shimizu; Masafumi Fukagawa; T Kuroda; S Hata; Y Iwasaki; M Nemoto; K Shirai; S Yamauchi; S B Margolin; F Shimizu; Kiyoshi Kurokawa
Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy.
Kidney international. Supplement 1997;63():S239-43.
1997: Masafumi Fukagawa; Masafumi Kitaoka; Kiyoshi Kurokawa
Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management.
Kidney international. Supplement 1997;62():S60-4.
1997: Masafumi Fukagawa; Masafumi Kitaoka; Takeshi Inazawa; Kiyoshi Kurokawa
Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects.
Current opinion in nephrology and hypertension 1997;6(4):349-55.
1997: Masafumi Fukagawa; Kiyoshi Kurokawa
Pathogenesis and medical treatment of secondary hyperparathyroidism.
Seminars in surgical oncology 1997;13(2):73-7.
1996: Masafumi Fukagawa; M Kitaoka; Kiyoshi Kurokawa
Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 3():125-9.
1995: Masafumi Fukagawa; H Yi; N Fukuda; Kiyoshi Kurokawa
Molecular basis for the management of secondary hyperparathyroidism in chronic renal failure.
Artificial organs 1995;19(12):1210-4.
1995: Masafumi Fukagawa; N Fukuda; H Yi; K Kurokawa
Resistance of parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(3):316-9.
1995: H Yi; Masafumi Fukagawa; H Yamato; M Kumagai; T Watanabe; Kiyoshi Kurokawa
Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
Nephron 1995;70(2):242-8.
1995: Masafumi Fukagawa; M Kitaoka; N Fukuda; H Yi; Kiyoshi Kurokawa
Pathogenesis and management of parathyroid hyperplasia in chronic renal failure: role of calcitriol.
Mineral and electrolyte metabolism 1995;21(1-3):97-100.
1994: Masafumi Fukagawa; M Kitaoka; H Yi; N Fukuda; T Matsumoto; E Ogata; Kiyoshi Kurokawa
Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.
Nephron 1994;68(2):221-8.
1993: Eisei Noiri; S Kuwata; Kazuo Nosaka; A Nakao; S Taniguchi; J Seki; S Uwatoko; K Suzuki; Masafumi Fukagawa; T Okuda
Shunt nephritis: efficacy of an antibiotic trial for clinical diagnosis.
Internal medicine (Tokyo, Japan) 1993;32(4):291-4.
1992: Masafumi Fukagawa; Kiyoshi Kurokawa
Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
Journal of nutritional science and vitaminology 1992;Spec No():96-9.
1992: T Takano; Masafumi Fukagawa; Kiyoshi Kurokawa
[Vitamin D metabolism in chronic kidney failure].
Nihon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():549-56.
1991: Masafumi Fukagawa; Shinya Kaname; Takashi Igarashi; E Ogata; Kiyoshi Kurokawa
Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
Kidney international 1991;39(5):874-81.
1990: Masafumi Fukagawa; R Okazaki; K Takano; Shinya Kaname; E Ogata; M Kitaoka; S Harada; N Sekine; T Matsumoto; Kiyoshi Kurokawa
Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis.
The New England journal of medicine 1990;323(6):421-2.
1989: M Yamamoto; Takashi Igarashi; M Muramatsu; Masafumi Fukagawa; Toru Motokura; E Ogata
Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat.
The Journal of clinical investigation 1989;83(3):1053-6.
1986: Masafumi Fukagawa; Shinya Kaname; K Hayashi; H Yamashita; K Masuda; K Kurokawa
Cyclosporine A nephrotoxicity in patients with Behçet's disease.
Developments in toxicology and environmental science 1986;14():129-33.